Top compounds associated with response to ATP13A3


Feature Type Standardized
Nominal ANOVA
mRNA ML311 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA SR1001 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA pac-1 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.027 0.4
mRNA Bosutinib FIMM pan-cancer AAC -0.3 0.4
Download CSV